We are live on ! Find out more
CLB icon

Core Laboratories

346 hedge funds and large institutions have $6.61B invested in Core Laboratories in 2014 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 137 increasing their positions, 122 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% more repeat investments, than reductions

Existing positions increased: 137 | Existing positions reduced: 122

2% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 42

0% more funds holding

Funds holding: 346346 (0)

0.51% less ownership

Funds ownership: 89.45%88.94% (-0.51%)

17% less capital invested

Capital invested by funds: $7.98B → $6.61B (-$1.37B)

27% less funds holding in top 10

Funds holding in top 10: 118 (-3)

45% less call options, than puts

Call options by funds: $29.5M | Put options by funds: $53.2M

Holders
346
Holders Change
Holders Change %
0%
% of All Funds
9.95%
Holding in Top 10
8
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-27.27%
% of All Funds
0.23%
New
43
Increased
137
Reduced
122
Closed
42
Calls
$29.5M
Puts
$53.2M
Net Calls
-$23.8M
Net Calls Change
+$4.89M
Name Holding Trade Value Shares
Change
Change in
Stake
VRS
101
Virginia Retirement Systems
Virginia
$7.47M -$3.63M -20,406 -31%
Swiss National Bank
102
Swiss National Bank
Switzerland
$7.3M -$53.4K -300 -0.7%
TMAM
103
Tokio Marine Asset Management
Japan
$7.12M +$7.37M +41,400 +3,450%
BIA
104
Biondo Investment Advisors
Pennsylvania
$6.92M +$2.06M +11,595 +39%
KBC Group
105
KBC Group
Belgium
$6.68M +$1.64M +9,200 +30%
ARTA
106
A.R.T. Advisors
New York
$6.27M +$6.68M +37,537 New
ACM
107
Atlanta Capital Management
Georgia
$5.9M +$5.68M +31,903 +930%
JP Morgan Chase
108
JP Morgan Chase
New York
$5.83M -$622K -3,498 -9%
ACM
109
Ashford Capital Management
Delaware
$5.65M +$689K +3,875 +13%
WFM
110
Wilmington Funds Management
Delaware
$5.49M +$1.67M +9,405 +40%
GP
111
GLG Partners
United Kingdom
$5.49M +$5.84M +32,836 New
OC
112
Oppenheimer & Co
New York
$5.3M -$140K -786 -2%
AAM
113
Advisors Asset Management
Colorado
$5.05M -$37.5K -211 -0.7%
Los Angeles Capital Management
114
Los Angeles Capital Management
California
$4.77M +$791K +4,444 +18%
AAF
115
Andra AP-fonden
Sweden
$4.76M -$1.81M -10,200 -26%
1IC
116
1919 Investment Counsel
Maryland
$4.6M -$187K -1,050 -4%
IGIM
117
I.G. Investment Management
Manitoba, Canada
$4.5M -$6.21M -34,913 -56%
DCLA
118
Douglas C. Lane & Associates
New York
$4.4M +$2.88M +16,171 +159%
DT
119
Diversified Trust
Tennessee
$4.39M +$4.68M +26,308 New
PNC Financial Services Group
120
PNC Financial Services Group
Pennsylvania
$4.34M +$102K +572 +2%
HIM
121
Hermes Investment Management
United Kingdom
$4.25M -$25.5M -143,479 -85%
AP
122
Appleton Partners
Massachusetts
$4.03M +$48.7K +274 +1%
SMDAM
123
Sumitomo Mitsui DS Asset Management
Japan
$3.85M +$3.28M +18,420 +399%
BlackRock
124
BlackRock
New York
$3.8M -$1.37M -7,683 -25%
MIU
125
Man Investments (UK)
United Kingdom
$3.8M +$2.95M +16,580 +268%

CLB Hedge Fund Activity: Q2 2014 in Review

346 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q2 2014, worth a combined $6.61B — down 17% from $7.98B a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new CLB positions and 42 closed out — a net gain of 1 holder — while 137 added to existing stakes and 122 trimmed.

The largest buyer was Vontobel Asset Management, adding an estimated $147M. The largest seller was Carmignac Gestion, exiting entirely with an estimated $604M sold.

  • 346 institutional investors held Core Laboratories (CLB) as of Q2 2014, unchanged from Q1 2014.
  • Funds reported $6.61B of Core Laboratories stock for Q2 2014, down 17% quarter-over-quarter.
  • 43 funds opened new Core Laboratories positions in Q2 2014 and 42 closed out, a net change of +1 holder.
  • The largest Core Laboratories buyer in Q2 2014 was Vontobel Asset Management, an estimated $147M added.
  • The largest Core Laboratories seller in Q2 2014 was Carmignac Gestion, an estimated $604M sold.

Based on aggregated 13F filings for Q2 2014.